Daniel M. Kerr
University of Glasgow
12 Papers
99 Citations
Daniel M. Kerr is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 7, co-authored 12 publications. Previous affiliations of Daniel M. Kerr include University of Edinburgh.
Chat about Author
Papers
Contemporary Outcome Measures in Acute Stroke Research: Choice of Primary Outcome Measure
Kennedy R. Lees,Philip M.W. Bath,Peter D. Schellinger,Daniel M. Kerr,Rachael L. Fulton,Werner Hacke,David B. Matchar,Ruchir Sehra,Danilo Toni +8 more
TL;DR: The modified Rankin Scale is imperfect but should be retained in its present form for comparability with existing treatment comparisons, and should be included in most acute trials, without seeking to restrict options for special circumstances.
230
Response of Blood Pressure and Blood Glucose to Treatment With Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke: Evidence From the Virtual International Stroke Trials Archive
Daniel M. Kerr,Rachael L. Fulton,Peter Higgins,Philip M.W. Bath,Ashfaq Shuaib,Patrick D. Lyden,Kennedy R. Lees +6 more
TL;DR: A stress response does not appear to be the principal cause of elevations in BP and glucose during stroke, and rtPA-treated patients were younger, less likely to have a history of hypertension or diabetes, and had more severe strokes on admission.
39
The association of child maltreatment and systemic inflammation in adulthood: A systematic review.
TL;DR: The most widely reported biomarkers were C-Reactive protein (CRP), interleukin-6 (IL-6) and Tumour Necrosis Factor-alpha (TNF-a) as discussed by the authors.
Associations with publication and assessing publication bias in dementia diagnostic test accuracy studies.
TL;DR: This work aimed to describe rates and predictors of publication of dementia test accuracy studies presented at scientific meetings and to quantify publication bias.
27
•Journal Article
Abstract 2481: Day 7 NIHSS is a Sensitive Outcome Measure for Exploratory Clinical Trials in Acute Stroke: Evidence from the Virtual International Stroke Trials Archive (VISTA)
TL;DR: 7 day NIHSS score appears a sensitive endpoint that should be validated in a randomised trial dataset for use in exploratory stroke trials.
21